CN103494916A - Traditional Chinese medicine composition with effect of reducing blood sugar, as well as preparation method and application thereof - Google Patents

Traditional Chinese medicine composition with effect of reducing blood sugar, as well as preparation method and application thereof Download PDF

Info

Publication number
CN103494916A
CN103494916A CN201310465427.4A CN201310465427A CN103494916A CN 103494916 A CN103494916 A CN 103494916A CN 201310465427 A CN201310465427 A CN 201310465427A CN 103494916 A CN103494916 A CN 103494916A
Authority
CN
China
Prior art keywords
chinese medicine
parts
medicine composition
effect
blood sugar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201310465427.4A
Other languages
Chinese (zh)
Other versions
CN103494916B (en
Inventor
张畅斌
沈林林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing University of Chinese Medicine
Original Assignee
Nanjing University of Chinese Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing University of Chinese Medicine filed Critical Nanjing University of Chinese Medicine
Priority to CN201310465427.4A priority Critical patent/CN103494916B/en
Publication of CN103494916A publication Critical patent/CN103494916A/en
Application granted granted Critical
Publication of CN103494916B publication Critical patent/CN103494916B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition with the effect of reducing blood sugar. The traditional Chinese medicine composition is prepared from the following active ingredients in parts by weight: 30-40 parts of hairy clovershrub root, 15-25 parts of motherwort herb, 8-12 parts of peach seed, 15-25 parts of dichrocephala integrifolia, 15-25 parts of immature bitter orange, 15-25 parts of Indian buead and 8-12 parts of liquorice root. The traditional Chinese medicine composition can be in the form of granules, tablets, oral liquid and capsules. The invention further discloses a preparation method of the traditional Chinese medicine composition. The preparation method comprises the following steps: adding water for decoction, concentrating, performing alcohol precipitation, performing spray-drying, and adding auxiliary materials to prepare the composition. The invention also discloses application of the traditional Chinese medicine composition to preparation of medicaments with the effect of reducing blood sugar.

Description

A kind of Chinese medicine composition with reduction blood glucose effect and its preparation method and application
Technical field
The present invention relates to Chinese medicine composition, be specifically related to a kind of Chinese medicine composition with effect of lowering blood sugar and its preparation method and application.
Background technology
Diabetes are one group and take the metabolic disease that hyperglycemia is feature.Hyperglycemia be due to defect of insulin secretion or its biological agent impaired, or both have concurrently and cause.Long-standing hyperglycemia during diabetes, cause various tissues, particularly chronic lesion, the dysfunction of eye, kidney, heart, blood vessel, nerve.The medicine of clinical treatment 2 types, except insulin, is mainly oral antidiabetic drug at present, roughly is divided into sulphanylureas, biguanides, Chinese medicine preparation, other antidiabetic drugs and adjuvant drug.But its side effect of these Oral Chemicals is mainly manifested in, blood phase, liver function, renal function are all had to certain detrimental effect, can cause patient's diabetic cardiovascular and cerebrovascular complication, hypoglycemic reaction easily appears, irritant to gastrointestinal, and produce anorexia, feel sick, vomiting diarrhoea etc. even.So selection is efficient and but life-time service is without any side effects, curative effect is reliable, the hypoglycemic medicine of taking convenience is badly in need of, Chinese medicine has certain curative effect for the treatment diabetes, the contrast Western medicine has the characteristics such as curative effect is high, toxic and side effects is little, but the curative effect of current Chinese medicine preparation treatment diabetes is not remarkable, can't bring into play the advantage of TCM treatment of diabetes.
Summary of the invention
Goal of the invention: in order to address the above problem, the object of the present invention is to provide a kind of Chinese medicine composition with effect of lowering blood sugar and its preparation method and application.
Technical scheme: the objective of the invention is to realize by following scheme:
A kind of Chinese medicine composition with effect of lowering blood sugar, extracted and be prepared from by the following raw materials in part by weight medicine: large and red 30-40 part, Herba Leonuri 15-25 part, Semen Persicae 8-12 part, Herba Houttuyniae 15-25 part, Fructus Aurantii Immaturus 15-25 part, Poria 15-25 part and Radix Glycyrrhizae 8-12 part.
Above-mentioned a kind of Chinese medicine composition with effect of lowering blood sugar, extracted and to be prepared from by the following raw materials in part by weight medicine: 20 parts of large and red 35 parts, Herba Leonuri, 10 parts, 10 parts, Semen Persicae, 20 parts of Herba Houttuyniae, 20 parts of Fructus Aurantii Immaturuss, 20 parts, Poria and Radix Glycyrrhizae.
The above-mentioned Chinese medicine composition with effect of lowering blood sugar, dosage form is granule, tablet, oral liquid, capsule.
The above-mentioned method with effect of lowering blood sugar Chinese medicine composition, preparation process is: get large and red, Herba Leonuri, Semen Persicae, Herba Houttuyniae, Fructus Aurantii Immaturus, Poria and licorice medicinal materials merge, decoct with water twice, collecting decoction, while being concentrated into 65 ℃, relative density is 1.10-1.20, add ethanol, stir, make to measure by volume percentage calculation containing alcohol and reach 65-85%, standing, filter, when filtrate decompression is concentrated into 65 ℃, relative density is 1.20-1.30 and reclaims ethanol and obtain concentrated solution, concentrated solution is added to adjuvant and make oral liquid, or by the concentrated solution spray drying, add adjuvant, the granulation agent, tablet or capsule.
The above-mentioned preparation method with effect of lowering blood sugar Chinese medicine composition, decocting condition is: the 8-12 that amount of water is medical material weight for the first time doubly measures, and decocts 1-2h, and the 6-10 that amount of water is medical material weight for the second time doubly measures, and decocts 1-2h.
The above-mentioned preparation method with effect of lowering blood sugar Chinese medicine composition, described spray drying condition is: inlet temperature is 90-110 ℃, and leaving air temp is 80-90 ℃, and temperature of charge is 80-90 ℃, and atomizing pressure is the 0.2-0.5 MPa, spray velocity is 1-10ml/s.
The above-mentioned Chinese medicine composition with effect of lowering blood sugar has the application in the effect of lowering blood sugar medicine in preparation.
Beneficial effect:
1, from theory of Chinese medical science, the diabetes traditional Chinese medical science is thought " quenching one's thirst " card, and this disease of " quenching one's thirst " in Treatise on Febrile Diseases is classified JUE YIN syndrome as, Fang Zhong great and red, Herba Leonuri, Semen Persicae are invigorated blood circulation, are regulated the flow of vital energy, pain relieving, are monarch drug altogether, the Herba Houttuyniae heat-clearing and toxic substances removing, dampness removing, Fructus Aurantii Immaturus promoting the circulation of QI and reducing phlegm, be ministerial drug altogether, Poria invigorating the spleen and regulating the stomach, Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription, be adjuvant altogether, all medicines are harmonious, and the effect of play altogether blood circulation promoting and blood stasis dispelling, clearing away heat and promoting production of body fluid, eliminating the phlegm, for the treatment of diabetes.
2, Formulation of the present invention is reasonable, and compatibility is rigorous.
3, the present invention consists of natural Chinese medicine, have no side effect, and low price.
The specific embodiment
Form by the following examples, foregoing of the present invention is described in further detail again, but this should be interpreted as to the scope of the above-mentioned theme of the present invention only limits to following example, all technology realized based on foregoing of the present invention all belong to scope of the present invention.
1,, in conjunction with the specific embodiment, the present invention is further described as follows:
According to the form below, listed weight proportion takes raw material required for the present invention, unit: g
? Large and red Herba Leonuri Semen Persicae Herba Houttuyniae Fructus Aurantii Immaturus Poria Radix Glycyrrhizae
Embodiment 1 30 25 8 25 15 25 8
Embodiment 2 35 20 10 20 20 20 10
Embodiment 3 35 20 10 20 20 20 10
Embodiment 4 40 15 12 15 25 15 15
In the present invention, large and red is the pulse family Hang Zi tip platymiscium Mao Hangzi tip, with root, be used as medicine, and the herb that Herba Houttuyniae is the little Herba Houttuyniae of feverfew or chrysanthemum leaf Herba Houttuyniae, all the other are the pharmacopeia kind.
2. Preparation Example
Above table Raw proportioning is example, comprises the following steps:
Embodiment 1: the preparation of granule
Taking medical material by each medical material consumption in upper table mixes, decoct with water twice, adding for the first time water is 8 times of amounts of medical material weight, decoct 1.5h, adding for the second time water is 6 times of amounts of medical material weight, decoct 1h, collecting decoction, filter, filtrate is concentrated into relative density 1.10 (65 ℃), adding appropriate ethanol makes to reach 65% containing alcohol amount (volume fraction), stir, standing 24 hours, filter, filtrate recycling ethanol also is concentrated into the concentrated solution of relative density 1.20 (65 ℃), it is spray-dried that (condition is that inlet temperature is 100 ℃, leaving air temp is 80 ℃, temperature of charge is 70 ℃, atomizing pressure is 0.2 MPa, spray velocity is 5ml/s.), being ground into dry extract, then adding suitable dextrin, mix homogeneously, with appropriate 80% ethanol moistening, soft material processed, cross 14 mesh sieves and granulate, 70 ℃ of dryings, 60 order granulate, obtain granule.
Embodiment 2: the preparation of tablet
Taking medical material by each medical material consumption in upper table mixes, decoct with water twice, add 10 times of amounts that water is medical material weight time, decoct 2h, adding for the second time water is 8 times of amounts of medical material weight, decoct 1h, collecting decoction, filter, filtrate is concentrated into relative density 1.15 (65 ℃), adding appropriate ethanol makes to reach 75% containing alcohol amount (volume fraction), stir, standing 24 hours, filter, filtrate recycling ethanol also is concentrated into the concentrated solution of relative density 1.25 (65 ℃), it is spray-dried that (condition is that inlet temperature is 120 ℃, leaving air temp is 90 ℃, temperature of charge is 80 ℃, atomizing pressure is 0.3 MPa, spray velocity is 7.5/s.), being ground into dry extract, then adding appropriate Icing Sugar, mix homogeneously, with appropriate 80% ethanol moistening, soft material processed, cross 30 mesh sieves and granulate, and in 70~80 ℃ of dryings, with 60 mesh sieve granulate, tabletting, sugar coating, packing, outer package, censorship is qualified, obtains finished product.
Embodiment 3: the preparation of oral liquid
Taking medical material by each medical material consumption in upper table mixes, decoct with water twice, adding for the first time water is 12 times of amounts of medical material weight, decoct 2h, adding for the second time water is 10 times of amounts of medical material weight, decoct 2h, collecting decoction, filter, filtrate is concentrated into relative density 1.20 (65 ℃), add appropriate ethanol and make to reach 85% containing alcohol amount (volume fraction), stir standing 24 hours, filter, filtrate recycling ethanol also is concentrated into the concentrated solution of relative density 1.30 (65 ℃), with sucrose and propanoic acid 0.1% or sodium benzoate 0.1%~0.25% etc., as antiseptic, obtains the oral liquid finished product.
Embodiment 4: the preparation of capsule
Taking medical material by each medical material consumption in upper table mixes, decoct with water twice, adding for the first time water is 10 times of amounts of medical material weight, decoct 1.5h, adding for the second time water is 8 times of amounts of medical material weight, decoct 1.5h, collecting decoction, filter, filtrate is concentrated into relative density 1.15 (65 ℃), adding appropriate ethanol makes to reach 75% containing alcohol amount (volume fraction), stir, standing 24 hours, filter, filtrate recycling ethanol also is concentrated into the concentrated solution of relative density 1.25 (65 ℃), it is spray-dried that (condition is that inlet temperature is 120 ℃, leaving air temp is 90 ℃, temperature of charge is 90 ℃, atomizing pressure is 0.4 MPa, spray velocity is 7.5/s.), be ground into dry extract, cross sieve No. 6, reinstall No. 1 capsule and get final product to obtain finished product.
3. hypoglycemic pharmacodynamic study falls
Of the present invention have reduce blood glucose on drug composition there is obvious reduction blood glucose action and efficacy, below with testing, further illustrate effect of the present invention:
Laboratory animal: (20 ± 2g) is male for Kunming mouse, and Shanghai Slac Experimental Animal Co., Ltd. provides, production licence: SCXK (Shanghai) 2007-0005.
Experimental agents: this Chinese medicine composition oral liquid, by above-mentioned oral liquid embodiment method preparation.
Take the large and red 35g of medical material, Herba Leonuri 20g, Semen Persicae 10g, Herba Houttuyniae 20g, Fructus Aurantii Immaturus 20g, Poria 20g and Radix Glycyrrhizae 10g mix, decoct with water twice, adding for the first time water is 12 times of amounts of medical material weight, decoct 2h, adding for the second time water is 10 times of amounts of medical material weight, decoct 2h, collecting decoction, filter, filtrate is concentrated into relative density 1.20 (65 ℃), adding appropriate ethanol makes to reach 85% containing alcohol amount (volume fraction), stir, standing 24 hours, filter, filtrate recycling ethanol also is concentrated into the concentrated solution of relative density 1.30 (65 ℃), with sucrose and propanoic acid 0.1% or sodium benzoate 0.1%~0.25% etc. as antiseptic, obtain 10 of oral liquid finished products, specification: 10mL/ props up (being equivalent to containing crude drug 13.5g), lot number: 20120815.Diabetes pill, Guangzhou Zhongyi Medicine Industry Co., Ltd's product, lot number 20120410, specification is the 30g/ bottle, 120 every bottle, 10 is 2.5g.Dosage: according to " the dose,equivalent ratio table of converting by surface between humans and animals ", every day, 70 kilograms of people's consumption was 67.5g, every day, the consumption of every 20g mice was 67.5*0.0026=0.1755g, because every oral liquid 10mL is 13.5g containing the crude drug amount, the consumption that is every mice is 0.13ml, therefore determine low dose of every gavage 0.1ml oral liquid, middle dosage and high dose be gavage 0.2ml and 0.4mL respectively, every day, the oral liquid of every 20g mouse stomach was respectively 0.135g containing the crude drug amount, 0.27g, 0.54g, press the Mice Body restatement, low dosage, middle dosage and high dose are respectively 6.75g crude drug amount/kg, 13.5g crude drug amount/kg and 27g crude drug amount/kg.
The positive drug diabetes pill, Guangzhou Zhongyi Medicine Industry Co., Ltd's product, lot number 20120310, specification is the 30g/ bottle, 120 every bottle, 10 is 2.5g, and patient uses general each 10, every day 2 times, be people's consumption per day 5g, being equivalent to every 20g mice consumption is 5*0.0026=0.013g, presses the per kilogram mice and calculates, and the positive drug group gives diabetes pill 0.65g/kg.
Instrument and reagent: alloxan (C 4h 2n 2o 4h 2o, molecular weight 160.08), blood glucose meter, full automatic biochemical apparatus, 721 spectrophotometers, microplate reader, balance.
Adaptability was raised after 1 day, got at random 10 mices as normal group, and another 90 animal fasting 3-5 hour survey fasting glucose, as this batch of animal basis blood glucose value.Animal fasting subsequently 24 hours (freely drinking water), lumbar injection alloxan (with front fresh preparation) 130mg/kg modeling, after 5 days, the animal fasting is 5 hours, surveys blood glucose, and blood glucose value 10~25mmol/L is hyperglycemia model success animal.
Select 40 of hyperglycemia model animals, blood sugar level grouping by fasting 3-5 hour, select at random 1 model control group and 4 dosage groups (the poor 1.1mmol/L that is not more than between group), every group of 10 animals, the dosage group gives the variable concentrations given the test agent, and model control group gives solvent, continuous 30 days, survey fasting blood sugar (fasting is with before testing), relatively each treated animal blood glucose value and blood glucose decline percentage rate.
Figure BSA0000095868140000051
The effect ((X scholar D) that the present invention descends to the sugared model mice blood glucose of height
Compare * * * p<0.001 with normal group, with model group, compare ###p<0.001, compare with the positive drug group $p<0.05.
Medicine of the present invention has hypoglycemic effect to the hyperglycemia mice, with blood glucose value after the model group comparative experiments, significantly reduces, and illustrates that the present invention has hypoglycemic effect.The high dose group of medicine of the present invention is compared with the positive drug group, and blood glucose descends significant difference, illustrates that the effect of medicine of the present invention is better than positive drug.

Claims (7)

1. the Chinese medicine composition with effect of lowering blood sugar, it is characterized in that extracting and being prepared from by the following raw materials in part by weight medicine: large and red 30-40 part, Herba Leonuri 15-25 part, Semen Persicae 8-12 part, Herba Houttuyniae 15-25 part, Fructus Aurantii Immaturus 15-25 part, Poria 15-25 part and Radix Glycyrrhizae 8-12 part.
2. a kind of Chinese medicine composition with effect of lowering blood sugar as claimed in claim 1, it is characterized in that extracting and being prepared from by the following raw materials in part by weight medicine: 20 parts of large and red 35 parts, Herba Leonuri, 10 parts, 10 parts, Semen Persicae, 20 parts of Herba Houttuyniae, 20 parts of Fructus Aurantii Immaturuss, 20 parts, Poria and Radix Glycyrrhizae.
3. there is as claimed in claim 1 or 2 the Chinese medicine composition of effect of lowering blood sugar, it is characterized in that dosage form is granule, tablet, oral liquid, capsule.
4. one kind prepares the method that has as claimed in claim 1 or 2 the effect of lowering blood sugar Chinese medicine composition, it is characterized in that preparation process is: get large and red, Herba Leonuri, Semen Persicae, Herba Houttuyniae, Fructus Aurantii Immaturus, Poria and licorice medicinal materials merge, decoct with water twice, collecting decoction, while being concentrated into 65 ℃, relative density is 1.10-1.20, add ethanol, stir, make to measure by volume percentage calculation containing alcohol and reach 65-85%, standing, filter, when filtrate decompression is concentrated into 65 ℃, relative density is 1.20-1.30 and reclaims ethanol and obtain concentrated solution, concentrated solution is added to adjuvant and make oral liquid, or by the concentrated solution spray drying, add adjuvant, the granulation agent, tablet or capsule.
5. there is as claimed in claim 4 the preparation method of effect of lowering blood sugar Chinese medicine composition, it is characterized in that, decocting condition is: the 8-12 that amount of water is medical material weight for the first time doubly measures, and decocts 1-2h, the 6-10 that amount of water is medical material weight for the second time doubly measures, and decocts 1-2h.
6. there is as claimed in claim 4 the preparation method of effect of lowering blood sugar Chinese medicine composition, it is characterized in that, described spray drying condition is: inlet temperature is 90-110 ℃, leaving air temp is 80-90 ℃, temperature of charge is 80-90 ℃, atomizing pressure is the 0.2-0.5 MPa, and spray velocity is 1-10ml/s.
7. the Chinese medicine composition with effect of lowering blood sugar as claimed in claim 1 or 2 has the application in the effect of lowering blood sugar medicine in preparation.
CN201310465427.4A 2013-10-09 2013-10-09 Traditional Chinese medicine composition with effect of reducing blood sugar, as well as preparation method and application thereof Expired - Fee Related CN103494916B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310465427.4A CN103494916B (en) 2013-10-09 2013-10-09 Traditional Chinese medicine composition with effect of reducing blood sugar, as well as preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310465427.4A CN103494916B (en) 2013-10-09 2013-10-09 Traditional Chinese medicine composition with effect of reducing blood sugar, as well as preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN103494916A true CN103494916A (en) 2014-01-08
CN103494916B CN103494916B (en) 2015-04-22

Family

ID=49860239

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310465427.4A Expired - Fee Related CN103494916B (en) 2013-10-09 2013-10-09 Traditional Chinese medicine composition with effect of reducing blood sugar, as well as preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN103494916B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104146255A (en) * 2014-08-18 2014-11-19 周玉梅 Chewable tablet suitable for patients with type II diabetes and preparation method thereof
CN104800758A (en) * 2015-04-30 2015-07-29 淄博齐鼎立专利信息咨询有限公司 Traditional Chinese medicine for reducing blood glucose

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101642547A (en) * 2009-06-14 2010-02-10 李承平 Chinese patent medicine for treating diabetes
CN101715850A (en) * 2009-11-13 2010-06-02 中国绿色食品实业有限公司 Health-preserving tea capable of preventing and treating diabetes mellitus and preparation method thereof
CN102047997A (en) * 2009-11-10 2011-05-11 上海市新文达生物科技有限公司 Wuyi Mountain rock tea extract, and preparation method and application thereof
KR101195109B1 (en) * 2009-08-20 2012-10-29 화 례 임 composition of health food

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101642547A (en) * 2009-06-14 2010-02-10 李承平 Chinese patent medicine for treating diabetes
KR101195109B1 (en) * 2009-08-20 2012-10-29 화 례 임 composition of health food
CN102047997A (en) * 2009-11-10 2011-05-11 上海市新文达生物科技有限公司 Wuyi Mountain rock tea extract, and preparation method and application thereof
CN101715850A (en) * 2009-11-13 2010-06-02 中国绿色食品实业有限公司 Health-preserving tea capable of preventing and treating diabetes mellitus and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
崔同寅: "《全国重名易混中药鉴别手册》", 31 October 1992, article "锈钉子", pages: 87 *
钟毅等: "胃肠舒治疗糖尿病性胃轻瘫的临床观察", 《中国中西医结合杂志》, vol. 25, no. 03, 31 March 2005 (2005-03-31) *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104146255A (en) * 2014-08-18 2014-11-19 周玉梅 Chewable tablet suitable for patients with type II diabetes and preparation method thereof
CN104146255B (en) * 2014-08-18 2016-02-24 于法周 A kind ofly be applicable to chewable tablets of type II diabetes people and preparation method thereof
CN104800758A (en) * 2015-04-30 2015-07-29 淄博齐鼎立专利信息咨询有限公司 Traditional Chinese medicine for reducing blood glucose

Also Published As

Publication number Publication date
CN103494916B (en) 2015-04-22

Similar Documents

Publication Publication Date Title
CN112972547A (en) Traditional Chinese medicine composition for treating qi-blood deficiency syndrome and preparation method and application thereof
CN103251856B (en) Traditional Chinese medicine preparation for benefiting Qi and nourishing blood and preparation method of traditional Chinese medicine preparation
CN102614281B (en) Chinese medicinal composition for improving anoxia endurance and preparation method and application thereof
CN103110846B (en) Traditional Chinese medical composition for treating hyperlipemia as well as preparation method and application thereof
CN102935130B (en) Traditional Chinese medicine composition for improving anoxia endurance as well as preparation method and application thereof
CN102258680A (en) Chinese medicinal composition for reliving physical fatigue and preparation method and use thereof
CN102178733B (en) Chinese medicinal preparation for treating diabetes and preparation method thereof
CN1923256A (en) Medicinal composition, its preparing method and quality controlling means
CN102614258B (en) Chinese medicinal composition with blood sugar reducing effect, and preparation method and application thereof
CN103271978B (en) Ginkgo leaf compound preparation for resisting oxygen deprivation and glucose deprivation and treating altitude sickness
CN102961584B (en) Traditional Chinese medicine composition capable of relieving fatigue, as well as preparation method and application thereof
CN103494916B (en) Traditional Chinese medicine composition with effect of reducing blood sugar, as well as preparation method and application thereof
CN102614280B (en) Chinese medicinal composition with blood fat reducing effect, and preparation method and application thereof
CN103494894B (en) A kind of have Chinese medicine composition reducing blood glucose effect and its preparation method and application
CN102614372B (en) Chinese medicinal composition for resisting fatigue, and preparation method and application thereof
CN110772552A (en) Ginseng tablet capable of improving immunity and preparation method thereof
CN104857087A (en) Pharmaceutic preparation with blood glucose reducing effect, and preparation method and application of pharmaceutic preparation
CN102626510B (en) Traditional Chinese medicine composite for treating diabetic cardiopathy and preparation method and applications thereof
CN104922295A (en) Blood-nourishing and blood-enriching traditional Chinese medicine composition
CN103919845B (en) A kind of pharmaceutical composition for improving anoxia endurance and its preparation method and application
CN102552861A (en) Ginseng Sini granules and preparing method thereof
CN104857143A (en) Medicinal preparation for improving anoxia endurance
CN107596008B (en) Preparation method of Gushukang preparation
CN107929512B (en) Method for preparing bone strengthening Longmu granules by adopting ultrahigh pressure extraction
CN101375996B (en) Brain-tonifying and intelligence-raising formulation and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150422

Termination date: 20171009